{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:42:45Z","timestamp":1784248965088,"version":"3.55.0"},"reference-count":136,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2020,6,10]],"date-time":"2020-06-10T00:00:00Z","timestamp":1591747200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,10]],"date-time":"2020-06-10T00:00:00Z","timestamp":1591747200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Neurol Neurosci Rep"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1007\/s11910-020-01048-0","type":"journal-article","created":{"date-parts":[[2020,6,10]],"date-time":"2020-06-10T05:02:44Z","timestamp":1591765364000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Sleep Disturbances in Patients with Autoimmune Encephalitis"],"prefix":"10.1007","volume":"20","author":[{"given":"Margaret S.","family":"Blattner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5133-5538","authenticated-orcid":false,"given":"Gregory S.","family":"Day","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,10]]},"reference":[{"key":"1048_CR1","doi-asserted-by":"crossref","unstructured":"Graus F, Titulaer MJ, Balu R, Benseler S, Bien CG, Cellucci T, et al. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol. 2016;15(4):391\u2013404.","DOI":"10.1016\/S1474-4422(15)00401-9"},{"key":"1048_CR2","doi-asserted-by":"crossref","unstructured":"Escudero D, Guasp M, Ari\u00f1o H, Gaig C, Mart\u00ednez-Hern\u00e1ndez E, Dalmau J, et al. Antibody-associated CNS syndromes without signs of inflammation in the elderly. Neurology. 2017;89(14):1471\u20135.","DOI":"10.1212\/WNL.0000000000004541"},{"key":"1048_CR3","doi-asserted-by":"publisher","first-page":"804","DOI":"10.3389\/fneur.2019.00804","volume":"10","author":"T Blinder","year":"2019","unstructured":"Blinder T, Lewerenz J. Cerebrospinal fluid findings in patients with autoimmune encephalitis-a systematic analysis. Front Neurol. 2019;10:804.","journal-title":"Front Neurol"},{"key":"1048_CR4","doi-asserted-by":"crossref","unstructured":"Dalmau J, Gleichman AJ, Hughes EG, Rossi JE, Peng X, Lai M, et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol. 2008;7(12):1091\u20138.","DOI":"10.1016\/S1474-4422(08)70224-2"},{"issue":"2","key":"1048_CR5","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1136\/jnnp-2011-300411","volume":"83","author":"C Finke","year":"2012","unstructured":"Finke C, Kopp UA, Pr\u00fcss H, Dalmau J, Wandinger KP, Ploner CJ. Cognitive deficits following anti-NMDA receptor encephalitis. J Neurol Neurosurg Psychiatry. 2012;83(2):195\u20138.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1048_CR6","doi-asserted-by":"crossref","unstructured":"Flanagan EP, McKeon A, Lennon VA, Boeve BF, Trenerry MR, Tan KM, et al. Autoimmune dementia: clinical course and predictors of immunotherapy response. Mayo Clin Proc. 2010;85(10):881\u201397.","DOI":"10.4065\/mcp.2010.0326"},{"key":"1048_CR7","doi-asserted-by":"crossref","unstructured":"McKeon GL, Robinson GA, Ryan AE, Blum S, Gillis D, Finke C, et al. Cognitive outcomes following anti-N-methyl-D-aspartate receptor encephalitis: a systematic review. J Clin Exp Neuropsychol. 2018;40(3):234\u201352.","DOI":"10.1080\/13803395.2017.1329408"},{"key":"1048_CR8","doi-asserted-by":"crossref","unstructured":"Titulaer MJ, McCracken L, Gabilondo I, Armangu\u00e9 T, Glaser C, Iizuka T, et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol. 2013;12(2):157\u201365.","DOI":"10.1016\/S1474-4422(12)70310-1"},{"key":"1048_CR9","doi-asserted-by":"crossref","unstructured":"Wang W, Li JM, Hu FY, Wang R, Hong Z, He L, et al. Anti-NMDA receptor encephalitis: clinical characteristics, predictors of outcome and the knowledge gap in Southwest China. Eur J Neurol. 2016;23(3):621\u20139.","DOI":"10.1111\/ene.12911"},{"issue":"5","key":"1048_CR10","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1017\/cjn.2018.33","volume":"45","author":"J Hebert","year":"2018","unstructured":"Hebert J, et al. Long-term cognitive outcomes in patients with autoimmune encephalitis. Can J Neurol Sci. 2018;45(5):540\u20134.","journal-title":"Can J Neurol Sci"},{"key":"1048_CR11","doi-asserted-by":"crossref","unstructured":"Dubey D, Pittock SJ, Kelly CR, McKeon A, Lopez-Chiriboga AS, Lennon VA, et al. Autoimmune encephalitis epidemiology and a comparison to infectious encephalitis. Ann Neurol. 2018;83(1):166\u201377.","DOI":"10.1002\/ana.25131"},{"key":"1048_CR12","doi-asserted-by":"crossref","unstructured":"Granerod J, Ambrose HE, Davies NW, Clewley JP, Walsh AL, Morgan D, et al. Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study. Lancet Infect Dis. 2010;10(12):835\u201344.","DOI":"10.1016\/S1473-3099(10)70222-X"},{"issue":"Pt 12","key":"1048_CR13","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1093\/brain\/124.12.2417","volume":"124","author":"R Liguori","year":"2001","unstructured":"Liguori R, et al. Morvan\u2019s syndrome: peripheral and central nervous system and cardiac involvement with antibodies to voltage-gated potassium channels. Brain. 2001;124(Pt 12):2417\u201326.","journal-title":"Brain"},{"issue":"6","key":"1048_CR14","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1097\/00004691-200411000-00008","volume":"21","author":"KA Josephs","year":"2004","unstructured":"Josephs KA, Silber MH, Fealey RD, Nippoldt TB, Auger RG, Vernino S. Neurophysiologic studies in Morvan syndrome. J Clin Neurophysiol. 2004;21(6):440\u20135.","journal-title":"J Clin Neurophysiol"},{"issue":"18","key":"1048_CR15","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1212\/WNL.0000000000003887","volume":"88","author":"C Gaig","year":"2017","unstructured":"\u2022\u2022 Gaig C, et al. Clinical manifestations of the anti-IgLON5 disease. Neurology. 2017;88(18):1736\u201343 This study includes detailed analysis of polysomnography in IgLON5 and provides detailed characterization of sleep disruption in this disease.","journal-title":"Neurology"},{"key":"1048_CR16","doi-asserted-by":"crossref","unstructured":"Honorat JA, Komorowski L, Josephs KA, Fechner K, St Louis EK, Hinson SR, et al. IgLON5 antibody: neurological accompaniments and outcomes in 20 patients. Neurol Neuroimmunol Neuroinflamm. 2017;4(5):e385.","DOI":"10.1212\/NXI.0000000000000385"},{"issue":"4","key":"1048_CR17","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1007\/s00415-019-09230-2","volume":"266","author":"MS Blattner","year":"2019","unstructured":"\u2022\u2022 Blattner MS, et al. Sleep disturbances are common in patients with autoimmune encephalitis. J Neurol. 2019;266(4):1007\u201315 This study details clinical sleep complaints and polysomnography findings in AE patients who were systematically screened for sleep disruption.","journal-title":"J Neurol"},{"key":"1048_CR18","doi-asserted-by":"publisher","unstructured":"Ju YS, et al. Slow wave sleep disruption increases cerebrospinal fluid amyloid-beta levels. Brain. 2017;140(8):2104\u201311. https:\/\/doi.org\/10.1126\/scitranslmed.aau6550.","DOI":"10.1126\/scitranslmed.aau6550"},{"key":"1048_CR19","doi-asserted-by":"publisher","unstructured":"Lucey BP, et al. Reduced non-rapid eye movement sleep is associated with tau pathology in early Alzheimer\u2019s disease. Sci Transl Med. 2019;11(474) https:\/\/doi.org\/10.1126\/scitranslmed.aau6550.","DOI":"10.1126\/scitranslmed.aau6550"},{"key":"1048_CR20","doi-asserted-by":"publisher","first-page":"e148","DOI":"10.1038\/emm.2014.121","volume":"47","author":"ES Musiek","year":"2015","unstructured":"Musiek ES, Xiong DD, Holtzman DM. Sleep, circadian rhythms, and the pathogenesis of Alzheimer disease. Exp Mol Med. 2015;47:e148.","journal-title":"Exp Mol Med"},{"issue":"1","key":"1048_CR21","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/nrneurol.2015.232","volume":"12","author":"I Fyfe","year":"2016","unstructured":"Fyfe I. Parkinson disease. Sleep disorder deficits suggest signature for early Parkinson disease. Nat Rev Neurol. 2016;12(1):3.","journal-title":"Nat Rev Neurol"},{"issue":"10","key":"1048_CR22","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1007\/s00415-012-6505-7","volume":"259","author":"M Louter","year":"2012","unstructured":"Louter M, Aarden WCCA, Lion J, Bloem BR, Overeem S. Recognition and diagnosis of sleep disorders in Parkinson\u2019s disease. J Neurol. 2012;259(10):2031\u201340.","journal-title":"J Neurol"},{"key":"1048_CR23","doi-asserted-by":"crossref","unstructured":"Kang P, de Bruin GS, Wang LH, Ward BA, Ances BM, Lim MM, et al. Sleep pathology in Creutzfeldt-Jakob disease. J Clin Sleep Med. 2016;12(7):1033\u20139.","DOI":"10.5664\/jcsm.5944"},{"key":"1048_CR24","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s40675-017-0087-y","volume":"3","author":"M Blattner","year":"2017","unstructured":"Blattner M, de Bruin G. Sleep disorders in human Prionopathies. Curr Sleep Med Rep. 2017;3:215\u201321.","journal-title":"Curr Sleep Med Rep"},{"issue":"6","key":"1048_CR25","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1007\/s00415-016-8083-6","volume":"263","author":"MR Brier","year":"2016","unstructured":"Brier MR, Day GS, Snyder AZ, Tanenbaum AB, Ances BM. N-Methyl-D-aspartate receptor encephalitis mediates loss of intrinsic activity measured by functional MRI. J Neurol. 2016;263(6):1083\u201391.","journal-title":"J Neurol"},{"key":"1048_CR26","doi-asserted-by":"crossref","unstructured":"Finke C, Kopp UA, Pajkert A, Behrens JR, Leypoldt F, Wuerfel JT, et al. Structural hippocampal damage following anti-N-methyl-D-aspartate receptor encephalitis. Biol Psychiatry. 2016;79(9):727\u201334.","DOI":"10.1016\/j.biopsych.2015.02.024"},{"key":"1048_CR27","doi-asserted-by":"crossref","unstructured":"Finke C, Kopp UA, Scheel M, Pech LM, Soemmer C, Schlichting J, et al. Functional and structural brain changes in anti-N-methyl-D-aspartate receptor encephalitis. Ann Neurol. 2013;74(2):284\u201396.","DOI":"10.1002\/ana.23932"},{"key":"1048_CR28","doi-asserted-by":"crossref","unstructured":"Heine J, Pr\u00fcss H, Kopp UA, Wegner F, Then Bergh F, M\u00fcnte T, et al. Beyond the limbic system: disruption and functional compensation of large-scale brain networks in patients with anti-LGI1 encephalitis. J Neurol Neurosurg Psychiatry. 2018;89(11):1191\u20139.","DOI":"10.1136\/jnnp-2017-317780"},{"key":"1048_CR29","doi-asserted-by":"crossref","unstructured":"Loane C, Argyropoulos GPD, Roca-Fern\u00e1ndez A, Lage C, Sheerin F, Ahmed S, et al. Hippocampal network abnormalities explain amnesia after VGKCC-Ab related autoimmune limbic encephalitis. J Neurol Neurosurg Psychiatry. 2019;90(9):965\u201374.","DOI":"10.1136\/jnnp-2018-320168"},{"issue":"10","key":"1048_CR30","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/S2215-0366(17)30330-9","volume":"4","author":"M Peer","year":"2017","unstructured":"Peer M, Pr\u00fcss H, Ben-Dayan I, Paul F, Arzy S, Finke C. Functional connectivity of large-scale brain networks in patients with anti-NMDA receptor encephalitis: an observational study. Lancet Psychiatry. 2017;4(10):768\u201374.","journal-title":"Lancet Psychiatry"},{"issue":"3","key":"1048_CR31","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1055\/s-0038-1660480","volume":"38","author":"JM Long","year":"2018","unstructured":"Long JM, Day GS. Autoimmune Dementia. Semin Neurol. 2018;38(3):303\u201315.","journal-title":"Semin Neurol"},{"issue":"2","key":"1048_CR32","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1212\/WNL.0b013e318224afde","volume":"77","author":"E Lancaster","year":"2011","unstructured":"Lancaster E, Martinez-Hernandez E, Dalmau J. Encephalitis and antibodies to synaptic and neuronal cell surface proteins. Neurology. 2011;77(2):179\u201389.","journal-title":"Neurology"},{"issue":"7","key":"1048_CR33","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/nrneurol.2012.99","volume":"8","author":"E Lancaster","year":"2012","unstructured":"Lancaster E, Dalmau J. Neuronal autoantigens-pathogenesis, associated disorders and antibody testing. Nat Rev Neurol. 2012;8(7):380\u201390.","journal-title":"Nat Rev Neurol"},{"key":"1048_CR34","doi-asserted-by":"crossref","unstructured":"Bien CG, Vincent A, Barnett MH, Becker AJ, Blumcke I, Graus F, et al. Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis. Brain. 2012;135(Pt 5):1622\u201338.","DOI":"10.1093\/brain\/aws082"},{"key":"1048_CR35","doi-asserted-by":"crossref","unstructured":"Dalmau J, Gultekin SH, Voltz R, Hoard R, DesChamps T, Balmaceda C, et al. Ma1, a novel neuron- and testis-specific protein, is recognized by the serum of patients with paraneoplastic neurological disorders. Brain. 1999;122:27\u201339.","DOI":"10.1093\/brain\/122.1.27"},{"issue":"2","key":"1048_CR36","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1212\/WNL.40.2.219","volume":"40","author":"F Graus","year":"1990","unstructured":"Graus F, Ribalta T, Campo E, Monforte R, Urbano A, Rozman C. Immunohistochemical analysis of the immune reaction in the nervous system in paraneoplastic encephalomyelitis. Neurology. 1990;40(2):219\u201322.","journal-title":"Neurology"},{"key":"1048_CR37","doi-asserted-by":"crossref","unstructured":"Verschuuren J, Chuang L, Rosenblum MK, Lieberman F, Pryor A, Posner JB, et al. Inflammatory infiltrates and complete absence of Purkinje cells in anti-Yo-associated paraneoplastic cerebellar degeneration. Acta Neuropathol. 1996;91(5):519\u201325.","DOI":"10.1007\/s004010050460"},{"key":"1048_CR38","doi-asserted-by":"crossref","unstructured":"Horta ES, Lennon VA, Lachance DH, Jenkins SM, Smith CY, McKeon A, et al. Neural autoantibody clusters aid diagnosis of cancer. Clin Cancer Res. 2014;20(14):3862\u20139.","DOI":"10.1158\/1078-0432.CCR-14-0652"},{"key":"1048_CR39","doi-asserted-by":"crossref","unstructured":"Irani SR, Alexander S, Waters P, Kleopa KA, Pettingill P, Zuliani L, et al. Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan\u2019s syndrome and acquired neuromyotonia. Brain. 2010;133(9):2734\u201348.","DOI":"10.1093\/brain\/awq213"},{"issue":"20","key":"1048_CR40","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1212\/01.wnl.0000312275.04260.a0","volume":"70","author":"KM Tan","year":"2008","unstructured":"Tan KM, Lennon VA, Klein CJ, Boeve BF, Pittock SJ. Clinical spectrum of voltage-gated potassium channel autoimmunity. Neurology. 2008;70(20):1883\u201390.","journal-title":"Neurology"},{"key":"1048_CR41","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1001\/archneurol.2011.106","volume":"68","author":"J Cornellius","year":"2011","unstructured":"Cornellius J, Pittock S, McKeon A. Sleep manifestations of voltage-gated potassium channel complex autoimmunity. Arch Neurol. 2011;68:733\u20138.","journal-title":"Arch Neurol"},{"key":"1048_CR42","doi-asserted-by":"crossref","unstructured":"van Sonderen A, Ari\u00f1o H, Petit-Pedrol M, Leypoldt F, K\u00f6rtv\u00e9lyessy P, Wandinger KP, et al. The clinical spectrum of Caspr2 antibody-associated disease. Neurology. 2016;87(5):521\u20138.","DOI":"10.1212\/WNL.0000000000002917"},{"key":"1048_CR43","doi-asserted-by":"crossref","unstructured":"Irani SR, Pettingill P, Kleopa KA, Schiza N, Waters P, Mazia C, et al. Morvan syndrome: clinical and serological observations in 29 cases. Ann Neurol. 2012;72(2):241\u201355.","DOI":"10.1002\/ana.23577"},{"issue":"3","key":"1048_CR44","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1212\/WNL.54.3.771","volume":"54","author":"PA Barber","year":"2000","unstructured":"Barber PA, Anderson NE, Vincent A. Morvan\u2019s syndrome associated with voltage-gated K+ channel antibodies. Neurology. 2000;54(3):771\u20132.","journal-title":"Neurology"},{"issue":"6","key":"1048_CR45","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1136\/jnnp.65.6.857","volume":"65","author":"EK Lee","year":"1998","unstructured":"Lee EK, Maselli RA, Ellis WG, Agius MA. Morvan\u2019s fibrillary chorea: a paraneoplastic manifestation of thymoma. J Neurol Neurosurg Psychiatry. 1998;65(6):857\u201362.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"1048_CR46","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S1474-4422(10)70253-2","volume":"10","author":"J Dalmau","year":"2011","unstructured":"Dalmau J, Lancaster E, Martinez-Hernandez E, Rosenfeld MR, Balice-Gordon R. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol. 2011;10(1):63\u201374.","journal-title":"Lancet Neurol"},{"issue":"6","key":"1048_CR47","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1002\/mdc3.12535","volume":"4","author":"H Morales-Briceno","year":"2017","unstructured":"Morales-Briceno H, Fung VSC. Isolated nocturnal occurrence of orofacial dyskinesias in N-methyl-D-aspartate receptor encephalitis-a new diagnostic clue. Mov Disord Clin Pract. 2017;4(6):884\u20136.","journal-title":"Mov Disord Clin Pract"},{"key":"1048_CR48","doi-asserted-by":"crossref","unstructured":"Dalmau J, T\u00fcz\u00fcn E, Wu HY, Masjuan J, Rossi JE, Voloschin A, et al. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol. 2007;61(1):25\u201336.","DOI":"10.1002\/ana.21050"},{"key":"1048_CR49","doi-asserted-by":"crossref","unstructured":"Vitaliani R, Mason W, Ances B, Zwerdling T, Jiang Z, Dalmau J. Paraneoplastic encephalitis, psychiatric symptoms, and hypoventilation in ovarian teratoma. Ann Neurol. 2005;58(4):594\u2013604.","DOI":"10.1002\/ana.20614"},{"key":"1048_CR50","doi-asserted-by":"crossref","unstructured":"Lai M, Hughes EG, Peng X, Zhou L, Gleichman AJ, Shu H, et al. AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location. Ann Neurol. 2009;65(4):424\u201334.","DOI":"10.1002\/ana.21589"},{"key":"1048_CR51","doi-asserted-by":"crossref","unstructured":"Hoftberger R, van Sonderen A, Leypoldt F, Houghton D, Geschwind M, Gelfand J, et al. Encephalitis and AMPA receptor antibodies: novel findings in a case series of 22 patients. Neurology. 2015;84(24):2403\u201312.","DOI":"10.1212\/WNL.0000000000001682"},{"issue":"3","key":"1048_CR52","doi-asserted-by":"publisher","first-page":"e01528","DOI":"10.1002\/brb3.1528","volume":"10","author":"Y Jia","year":"2020","unstructured":"Jia Y, et al. Limbic encephalitis associated with AMPA receptor and CRMP5 antibodies: a case report and literature review. Brain Behav. 2020;10(3):e01528.","journal-title":"Brain Behav"},{"key":"1048_CR53","doi-asserted-by":"crossref","unstructured":"Guan HZ, Ren HT, Yang XZ, Lu Q, Peng B, Zhu YC, et al. Limbic encephalitis associated with anti-gamma-aminobutyric acid B receptor antibodies: a case series from China. Chin Med J. 2015;128(22):3023\u20138.","DOI":"10.4103\/0366-6999.168989"},{"key":"1048_CR54","doi-asserted-by":"crossref","unstructured":"Sabater L, Gaig C, Gelpi E, Bataller L, Lewerenz J, Torres-Vega E, et al. A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: a case series, characterisation of the antigen, and post-mortem study. Lancet Neurol. 2014;13(6):575\u201386.","DOI":"10.1016\/S1474-4422(14)70051-1"},{"issue":"Pt 8","key":"1048_CR55","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1093\/brain\/awh203","volume":"127","author":"J Dalmau","year":"2004","unstructured":"Dalmau J, et al. Clinical analysis of anti-Ma2-associated encephalitis. Brain. 2004;127(Pt 8):1831\u201344.","journal-title":"Brain"},{"key":"1048_CR56","doi-asserted-by":"crossref","unstructured":"Hoffmann LA, Jarius S, Pellkofer HL, Schueller M, Krumbholz M, Koenig F, et al. Anti-Ma and anti-ta associated paraneoplastic neurological syndromes: 22 newly diagnosed patients and review of previous cases. J Neurol Neurosurg Psychiatry. 2008;79(7):767\u201373.","DOI":"10.1136\/jnnp.2007.118588"},{"issue":"3","key":"1048_CR57","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1215\/S1152851702000467","volume":"5","author":"JC Landolfi","year":"2003","unstructured":"Landolfi JC, Nadkarni M. Paraneoplastic limbic encephalitis and possible narcolepsy in a patient with testicular cancer: case study. Neuro-Oncology. 2003;5(3):214\u20136.","journal-title":"Neuro-Oncology"},{"key":"1048_CR58","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1093\/sleep\/30.6.767","volume":"30","author":"Y Compta","year":"2007","unstructured":"Compta Y, Iranzo A, Santamar\u00eda J, Casamitjana R, Graus F. REM sleep behavior disorder and narcolpetic features in anti-Ma2 encephalitis. Sleep. 2007;30:767\u20139.","journal-title":"Sleep"},{"key":"1048_CR59","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Dauvilliers Y, et al. Hypothalamic immunopathology in anti-Ma-associated diencephalitis with narcolepsy-cataplexy. JAMA Neurol. 2013;70(10):1305\u201310 This case supports a CD8+ inflammatory-mediated targeting of hypocretin neurons as the mechanism that underlies narcolepsy and cataplexy associated with ma autoantibodies.","DOI":"10.1001\/jamaneurol.2013.2831"},{"issue":"4","key":"1048_CR60","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1001\/archneurol.2011.56","volume":"68","author":"C Adams","year":"2011","unstructured":"Adams C, McKeon A, Silber MH, Kumar R. Narcolepsy, REM sleep behavior disorder, and supranuclear gaze palsy associated with Ma1 and Ma2 antibodies and tonsillar carcinoma. Arch Neurol. 2011;68(4):521\u20134.","journal-title":"Arch Neurol"},{"issue":"5","key":"1048_CR61","doi-asserted-by":"publisher","first-page":"e39","DOI":"10.1016\/j.biopsych.2016.12.014","volume":"83","author":"I Kritikou","year":"2018","unstructured":"Kritikou I, Vgontzas AN, Rapp MA, Bixler EO. Anti-Ma1- and anti-Ma2-associated encephalitis manifesting with rapid eye movement sleep disorder and narcolepsy with cataplexy: a case report. Biol Psychiatry. 2018;83(5):e39\u201340.","journal-title":"Biol Psychiatry"},{"key":"1048_CR62","doi-asserted-by":"crossref","unstructured":"Vitiello M, Antelmi E, Pizza F, Postiglione E, Poggi R, Liguori R, et al. Type 1 narcolepsy in anti-Hu antibodies mediated encephalitis: a case report. Sleep Med. 2018;52:23\u20135.","DOI":"10.1016\/j.sleep.2018.02.003"},{"key":"1048_CR63","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.sleep.2015.11.012","volume":"21","author":"DA Barone","year":"2016","unstructured":"Barone DA, Krieger AC. Sleep disturbances in voltage-gated potassium channel antibody syndrome. Sleep Med. 2016;21:171\u20133.","journal-title":"Sleep Med"},{"key":"1048_CR64","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/978-3-319-90152-7_8","volume-title":"Rapid-Eye-Movement Sleep Behavior Disorder","author":"A Iranzo","year":"2019","unstructured":"Iranzo A. RBD associated with paraneoplastic neurological syndromes and autoimmune disorders. In: Schenck C, H\u00f6gl B, Videnovic A, editors. Rapid-Eye-Movement Sleep Behavior Disorder; 2019. p. 93\u2013106."},{"issue":"8","key":"1048_CR65","first-page":"565","volume":"51","author":"H Sun","year":"2018","unstructured":"Sun H, et al. Study of sleep disorders in patients with limbic encephalitis associated with anti leucine rich glioma inactivated protein 1 antibody. Chin J Neurol. 2018;51(8):565\u20139.","journal-title":"Chin J Neurol"},{"key":"1048_CR66","doi-asserted-by":"crossref","unstructured":"Iranzo A, Graus F, Clover L, Morera J, Bruna J, Vilar C, et al. Rapid eye movement sleep behavior disorder and potassium channel antibody-associated limbic encephalitis. Ann Neurol. 2006;59(1):178\u201381.","DOI":"10.1002\/ana.20693"},{"issue":"4","key":"1048_CR67","first-page":"320","volume":"55","author":"E Serdaro\u011flu","year":"2018","unstructured":"Serdaro\u011flu E, Tezer F, Saygi S. Autoimmune epilepsy and\/or limbic encephalitis can lead to changes in sleep spindles. Arch Neuropsychiatry. 2018;55(4):320\u20134.","journal-title":"Arch Neuropsychiatry"},{"issue":"4","key":"1048_CR68","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1053\/smrv.2001.0166","volume":"5","author":"E Lugaresi","year":"2001","unstructured":"Lugaresi E, Provini F. Agrypnia excitata: clinical features and pathophysiological implications. Sleep Med Rev. 2001;5(4):313\u201322.","journal-title":"Sleep Med Rev"},{"issue":"3","key":"1048_CR69","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S2215-0366(19)30001-X","volume":"6","author":"A Al-Diwani","year":"2019","unstructured":"Al-Diwani A, et al. The psychopathology of NMDAR-antibody encephalitis in adults: a systematic review and phenotypic analysis of individual patient data. Lancet Psychiatry. 2019;6(3):235\u201346.","journal-title":"Lancet Psychiatry"},{"issue":"1\u20132","key":"1048_CR70","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.jns.2013.10.034","volume":"336","author":"IB Marques","year":"2014","unstructured":"Marques IB, Teot\u00f3nio R, Cunha C, Bento C, Sales F. Anti-NMDA receptor encephalitis presenting with total insomnia--a case report. J Neurol Sci. 2014;336(1\u20132):276\u201380.","journal-title":"J Neurol Sci"},{"key":"1048_CR71","doi-asserted-by":"crossref","unstructured":"Iizuka T, Sakai F, Ide T, Monzen T, Yoshii S, Iigaya M, et al. Anti-NMDA receptor encephalitis in Japan: long-term outcome without tumor removal. Neurology. 2008;70(7):504\u201311.","DOI":"10.1212\/01.wnl.0000278388.90370.c3"},{"key":"1048_CR72","doi-asserted-by":"crossref","unstructured":"Uchino A, Iizuka T, Urano Y, Arai M, Hara A, Hamada J, et al. Pseudo-piano playing motions and nocturnal hypoventilation in anti-NMDA receptor encephalitis: response to prompt tumor removal and immunotherapy. Intern Med. 2011;50(6):627\u201330.","DOI":"10.2169\/internalmedicine.50.4764"},{"key":"1048_CR73","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jneuroim.2019.03.010","volume":"332","author":"B Freund","year":"2019","unstructured":"Freund B, Ritzl EK. A review of EEG in anti-NMDA receptor encephalitis. J Neuroimmunol. 2019;332:64\u20138.","journal-title":"J Neuroimmunol"},{"issue":"10","key":"1048_CR74","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1016\/j.clinph.2018.02.130","volume":"129","author":"C Steriade","year":"2018","unstructured":"Steriade C, Hantus S, Moosa ANV, Rae-Grant AD. Extreme delta - with or without brushes: a potential surrogate marker of disease activity in anti-NMDA-receptor encephalitis. Clin Neurophysiol. 2018;129(10):2197\u2013204.","journal-title":"Clin Neurophysiol"},{"issue":"11","key":"1048_CR75","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1212\/WNL.0b013e3182698cd8","volume":"79","author":"SE Schmitt","year":"2012","unstructured":"Schmitt SE, Pargeon K, Frechette ES, Hirsch LJ, Dalmau J, Friedman D. Extreme delta brush: a unique EEG pattern in adults with anti-NMDA receptor encephalitis. Neurology. 2012;79(11):1094\u2013100.","journal-title":"Neurology"},{"key":"1048_CR76","doi-asserted-by":"crossref","unstructured":"Jeannin-Mayer S, Andr\u00e9-Obadia N, Rosenberg S, Boutet C, Honnorat J, Antoine JC, et al. EEG analysis in anti-NMDA receptor encephalitis: description of typical patterns. Clin Neurophysiol. 2019;130(2):289\u201396.","DOI":"10.1016\/j.clinph.2018.10.017"},{"issue":"2","key":"1048_CR77","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1007\/s00415-018-9153-8","volume":"266","author":"O Laurido-Soto","year":"2019","unstructured":"Laurido-Soto O, Brier MR, Simon LE, McCullough A, Bucelli RC, Day GS. Patient characteristics and outcome associations in AMPA receptor encephalitis. J Neurol. 2019;266(2):450\u201360.","journal-title":"J Neurol"},{"key":"1048_CR78","doi-asserted-by":"publisher","unstructured":"Gaig C, Iranzo A, Cajochen C, Vilaseca I, Embid C, Dalmau J, et al. Characterization of the sleep disorder of anti-IgLON5 disease. Sleep. 2019;42 https:\/\/doi.org\/10.1093\/sleep\/zsz133.","DOI":"10.1093\/sleep\/zsz133"},{"key":"1048_CR79","doi-asserted-by":"crossref","unstructured":"Kim AE, Kang P, Bucelli RC, Ferguson CJ, Schmidt RE, Varadhachary AS, et al. Autoimmune encephalitis with multiple autoantibodies: a diagnostic and therapeutic challenge. Neurologist. 2018;23(2):55\u20139.","DOI":"10.1097\/NRL.0000000000000171"},{"issue":"5","key":"1048_CR80","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1093\/sleep\/34.5.601","volume":"34","author":"CM Morin","year":"2011","unstructured":"Morin CM, Belleville G, B\u00e9langer L, Ivers H. The Insomnia Severity Index: psychometric indicators to detect insomnia cases and evaluate treatment response. Sleep. 2011;34(5):601\u20138.","journal-title":"Sleep"},{"issue":"2","key":"1048_CR81","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/0165-1781(89)90047-4","volume":"28","author":"DJ Buysse","year":"1989","unstructured":"Buysse DJ, Reynolds CF III, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28(2):193\u2013213.","journal-title":"Psychiatry Res"},{"issue":"16","key":"1048_CR82","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1002\/mds.21740","volume":"22","author":"K Stiasny-Kolster","year":"2007","unstructured":"Stiasny-Kolster K, Mayer G, Sch\u00e4fer S, M\u00f6ller JC, Heinzel-Gutenbrunner M, Oertel WH. The REM sleep behavior disorder screening questionnaire--a new diagnostic instrument. Mov Disord. 2007;22(16):2386\u201393.","journal-title":"Mov Disord"},{"key":"1048_CR83","doi-asserted-by":"crossref","unstructured":"Dauvilliers Y, Beziat S, Pesenti C, Lopez R, Barateau L, Carlander B, et al. Measurement of narcolepsy symptoms: the narcolepsy severity scale. Neurology. 2017;88(14):1358\u201365.","DOI":"10.1212\/WNL.0000000000003787"},{"issue":"6","key":"1048_CR84","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1093\/sleep\/14.6.540","volume":"14","author":"MW Johns","year":"1991","unstructured":"Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep. 1991;14(6):540\u20135.","journal-title":"Sleep"},{"issue":"3","key":"1048_CR85","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1378\/chest.15-0903","volume":"149","author":"F Chung","year":"2016","unstructured":"Chung F, Abdullah HR, Liao P. STOP-Bang questionnaire: a practical approach to screen for obstructive sleep apnea. Chest. 2016;149(3):631\u20138.","journal-title":"Chest"},{"issue":"5","key":"1048_CR86","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/S1474-4422(15)00021-6","volume":"14","author":"D Riemann","year":"2015","unstructured":"Riemann D, Nissen C, Palagini L, Otte A, Perlis ML, Spiegelhalder K. The neurobiology, investigation, and treatment of chronic insomnia. Lancet Neurol. 2015;14(5):547\u201358.","journal-title":"Lancet Neurol"},{"issue":"6","key":"1048_CR87","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.neuron.2010.11.032","volume":"68","author":"CB Saper","year":"2010","unstructured":"Saper CB, Fuller PM, Pedersen NP, Lu J, Scammell TE. Sleep state switching. Neuron. 2010;68(6):1023\u201342.","journal-title":"Neuron"},{"key":"1048_CR88","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1177\/1545968304271405","volume":"18","author":"M Quellet","year":"2004","unstructured":"Quellet M, Savard J, Morin C. Insomnia following traumatic brain injury: a review. Neurorehabil Neural Repair. 2004;18:187\u201398.","journal-title":"Neurorehabil Neural Repair"},{"issue":"47","key":"1048_CR89","doi-asserted-by":"publisher","first-page":"16041","DOI":"10.1523\/JNEUROSCI.3745-10.2010","volume":"30","author":"M Koenigs","year":"2010","unstructured":"Koenigs M, Holliday J, Solomon J, Grafman J. Left dorsomedial frontal brain damage is associated with insomnia. J Neurosci. 2010;30(47):16041\u20133.","journal-title":"J Neurosci"},{"issue":"6","key":"1048_CR90","doi-asserted-by":"publisher","first-page":"i2123","DOI":"10.1136\/bmj.i2123","volume":"354","author":"M Kay-Stacey","year":"2016","unstructured":"Kay-Stacey M, Attarian H. Advances in the management of chronic insomnia. BMJ. 2016;354(6):i2123.","journal-title":"BMJ"},{"issue":"2","key":"1048_CR91","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/s41583-018-0097-x","volume":"20","author":"CE Mahoney","year":"2019","unstructured":"Mahoney CE, Cogswell A, Koralnik IJ, Scammell TE. The neurobiological basis of narcolepsy. Nat Rev Neurosci. 2019;20(2):83\u201393.","journal-title":"Nat Rev Neurosci"},{"key":"1048_CR92","doi-asserted-by":"crossref","unstructured":"Peyron C, Tighe DK, van den Pol AN, de Lecea L, Heller HC, Sutcliffe JG, et al. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci. 1998;18(23):9996\u201310015.","DOI":"10.1523\/JNEUROSCI.18-23-09996.1998"},{"issue":"1","key":"1048_CR93","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/s41598-018-36942-8","volume":"9","author":"N Sakai","year":"2019","unstructured":"Sakai N, Matsumura M, Lin L, Mignot E, Nishino S. HPLC analysis of CSF hypocretin-1 in type 1 and 2 narcolepsy. Sci Rep. 2019;9(1):477.","journal-title":"Sci Rep"},{"key":"1048_CR94","doi-asserted-by":"crossref","unstructured":"Overeem S, Dalmau J, Bataller L, Nishino S, Mignot E, Verschuuren J, et al. Anti-Ma2 antibodies in idiopathic and paraneoplastic hypocretin-deficient narcolepsy. Neurology. 2004;62:138\u201340.","DOI":"10.1212\/01.WNL.0000101718.92619.67"},{"issue":"10","key":"1048_CR95","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s11940-016-0429-y","volume":"18","author":"L Barateau","year":"2016","unstructured":"Barateau L, Lopez R, Dauvilliers Y. Management of Narcolepsy. Curr Treat Options Neurol. 2016;18(10):43.","journal-title":"Curr Treat Options Neurol"},{"key":"1048_CR96","doi-asserted-by":"crossref","unstructured":"Boeve BF, Silber MH, Saper CB, Ferman TJ, Dickson DW, Parisi JE, et al. Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease. Brain. 2007;130(Pt 11):2770\u201388.","DOI":"10.1093\/brain\/awm056"},{"issue":"29","key":"1048_CR97","doi-asserted-by":"publisher","first-page":"9785","DOI":"10.1523\/JNEUROSCI.0482-12.2012","volume":"32","author":"PL Brooks","year":"2012","unstructured":"Brooks PL, Peever JH. Identification of the transmitter and receptor mechanisms responsible for REM sleep paralysis. J Neurosci. 2012;32(29):9785\u201395.","journal-title":"J Neurosci"},{"issue":"7093","key":"1048_CR98","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/nature04767","volume":"441","author":"J Lu","year":"2006","unstructured":"Lu J, Sherman D, Devor M, Saper CB. A putative flip-flop switch for control of REM sleep. Nature. 2006;441(7093):589\u201394.","journal-title":"Nature"},{"issue":"1","key":"1048_CR99","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s10072-016-2744-1","volume":"38","author":"X Zhang","year":"2017","unstructured":"Zhang X, Sun X, Wang J, Tang L, Xie A. Prevalence of rapid eye movement sleep behavior disorder (RBD) in Parkinson\u2019s disease: a meta and meta-regression analysis. Neurol Sci. 2017;38(1):163\u201370.","journal-title":"Neurol Sci"},{"key":"1048_CR100","doi-asserted-by":"crossref","unstructured":"McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor JP, Weintraub D, et al. Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB Consortium. Neurology. 2017;89(1):88\u2013100.","DOI":"10.1212\/WNL.0000000000004058"},{"key":"1048_CR101","doi-asserted-by":"crossref","unstructured":"Boeve BF, Silber MH, Ferman TJ, Lin SC, Benarroch EE, Schmeichel AM, et al. Clinicopathologic correlations in 172 cases of rapid eye movement sleep behavior disorder with or without a coexisting neurologic disorder. Sleep Med. 2013;14(8):754\u201362.","DOI":"10.1016\/j.sleep.2012.10.015"},{"issue":"11","key":"1048_CR102","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/nrneurol.2016.152","volume":"12","author":"RB Postuma","year":"2016","unstructured":"Postuma RB, Berg D. Advances in markers of prodromal Parkinson disease. Nat Rev Neurol. 2016;12(11):622\u201334.","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"1048_CR103","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/nrneurol.2017.157","volume":"14","author":"B Hogl","year":"2018","unstructured":"Hogl B, Stefani A, Videnovic A. Idiopathic REM sleep behaviour disorder and neurodegeneration - an update. Nat Rev Neurol. 2018;14(1):40\u201355.","journal-title":"Nat Rev Neurol"},{"issue":"9","key":"1048_CR104","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/j.sleep.2008.12.006","volume":"10","author":"N Limousin","year":"2009","unstructured":"Limousin N, Dehais C, Gout O, H\u00e9ran F, Oudiette D, Arnulf I. A brainstem inflammatory lesion causing REM sleep behavior disorder and sleepwalking (parasomnia overlap disorder). Sleep Med. 2009;10(9):1059\u201362.","journal-title":"Sleep Med"},{"key":"1048_CR105","doi-asserted-by":"crossref","unstructured":"McCarter SJ, Tippmann-Peikert M, Sandness DJ, Flanagan EP, Kantarci K, Boeve BF, et al. Neuroimaging-evident lesional pathology associated with REM sleep behavior disorder. Sleep Med. 2015;16(12):1502\u201310.","DOI":"10.1016\/j.sleep.2015.07.018"},{"key":"1048_CR106","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1093\/brain\/awp320","volume":"133","author":"S Knudsen","year":"2010","unstructured":"Knudsen S, Gammeltoft S, Jennum PJ. Rapid eye movement sleep behaviour disorder in patients with narcolepsy is associated with hypocretin-1 deficiency. Brain. 2010;133:568\u201379.","journal-title":"Brain"},{"issue":"5","key":"1048_CR107","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.tins.2014.02.009","volume":"37","author":"J Peever","year":"2014","unstructured":"Peever J, Luppi PH, Montplaisir J. Breakdown in REM sleep circuitry underlies REM sleep behavior disorder. Trends Neurosci. 2014;37(5):279\u201388.","journal-title":"Trends Neurosci"},{"issue":"11","key":"1048_CR108","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1016\/j.mayocp.2017.09.007","volume":"92","author":"EK St Louis","year":"2017","unstructured":"St Louis EK, Boeve BF. REM sleep behavior disorder: diagnosis, clinical implications, and future directions. Mayo Clin Proc. 2017;92(11):1723\u201336.","journal-title":"Mayo Clin Proc"},{"key":"1048_CR109","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1159\/000478914","volume":"41","author":"CL Bassetti","year":"2018","unstructured":"Bassetti CL, Bargiotas P. REM sleep behavior disorder. Front Neurol Neurosci. 2018;41:104\u201316.","journal-title":"Front Neurol Neurosci"},{"issue":"3672","key":"1048_CR110","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1126\/science.148.3672.975","volume":"148","author":"A Jacobson","year":"1965","unstructured":"Jacobson A, Kales A, Lehmann D, Zweizig JR. Somnambulism: all-night electroencephalographic studies. Science. 1965;148(3672):975\u20137.","journal-title":"Science"},{"issue":"8","key":"1048_CR111","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1038\/s41582-018-0030-y","volume":"14","author":"A Castelnovo","year":"2018","unstructured":"Castelnovo A, Lopez R, Proserpio P, Nobili L, Dauvilliers Y. NREM sleep parasomnias as disorders of sleep-state dissociation. Nat Rev Neurol. 2018;14(8):470\u201381.","journal-title":"Nat Rev Neurol"},{"issue":"7","key":"1048_CR112","doi-asserted-by":"publisher","first-page":"2653","DOI":"10.1523\/JNEUROSCI.18-07-02653.1998","volume":"18","author":"EG Cape","year":"1998","unstructured":"Cape EG, Jones BE. Differential modulation of high-frequency gamma-electroencephalogram activity and sleep-wake state by noradrenaline and serotonin microinjections into the region of cholinergic basalis neurons. J Neurosci. 1998;18(7):2653\u201366.","journal-title":"J Neurosci"},{"key":"1048_CR113","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1192\/bjp.135.5.418","volume":"135","author":"DS Charney","year":"1979","unstructured":"Charney DS, Kales A, Soldatos CR, Nelson JC. Somnambulistic-like episodes secondary to combined lithium-neuroleptic treatment. Br J Psychiatry. 1979;135:418\u201324.","journal-title":"Br J Psychiatry"},{"issue":"1","key":"1048_CR114","first-page":"72","volume":"6","author":"F Faridhosseini","year":"2012","unstructured":"Faridhosseini F, Zamani A. A case report of somnambulism associated with olanzapine. Iran J Psychiatry Behav Sci. 2012;6(1):72\u20134.","journal-title":"Iran J Psychiatry Behav Sci"},{"issue":"4","key":"1048_CR115","doi-asserted-by":"publisher","first-page":"483","DOI":"10.4088\/JCP.v64n0420e","volume":"64","author":"T Kawashima","year":"2003","unstructured":"Kawashima T, Yamada S. Paroxetine-induced somnambulism. J Clin Psychiatry. 2003;64(4):483.","journal-title":"J Clin Psychiatry"},{"issue":"7","key":"1048_CR116","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1176\/appi.ajp.158.7.1158","volume":"158","author":"TT Kolivakis","year":"2001","unstructured":"Kolivakis TT, et al. Olanzapine-induced somnambulism. Am J Psychiatry. 2001;158(7):1158.","journal-title":"Am J Psychiatry"},{"issue":"5","key":"1048_CR117","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.smrv.2011.09.001","volume":"16","author":"R Boscolo-Berto","year":"2012","unstructured":"Boscolo-Berto R, Viel G, Montagnese S, Raduazzo DI, Ferrara SD, Dauvilliers Y. Narcolepsy and effectiveness of gamma-hydroxybutyrate (GHB): a systematic review and meta-analysis of randomized controlled trials. Sleep Med Rev. 2012;16(5):431\u201343.","journal-title":"Sleep Med Rev"},{"key":"1048_CR118","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.neurol.2016.09.018","volume":"173","author":"R Lopez","year":"2017","unstructured":"Lopez R, et al. French consensus. Management of patients with hypersomnia: which strategy? Rev Neurol. 2017;173:8\u201318.","journal-title":"Rev Neurol"},{"key":"1048_CR119","doi-asserted-by":"crossref","unstructured":"Hoftberger R, Titulaer MJ, Sabater L, Dome B, Rozsas A, Hegedus B, et al. Encephalitis and GABAB receptor antibodies: novel findings in a new case series of 20 patients. Neurology. 2013;81(17):1500\u20136.","DOI":"10.1212\/WNL.0b013e3182a9585f"},{"key":"1048_CR120","doi-asserted-by":"crossref","unstructured":"Drakatos P, Marples L, Muza R, Higgins S, Gildeh N, Macavei R, et al. NREM parasomnias: a treatment approach based upon a retrospective case series of 512 patients. Sleep Med. 2019;53:181\u20138.","DOI":"10.1016\/j.sleep.2018.03.021"},{"issue":"1","key":"1048_CR121","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1055\/s-2005-867074","volume":"25","author":"F Provini","year":"2005","unstructured":"Provini F, Lombardi C, Lugaresi E. Insomnia in neurological diseases. Semin Neurol. 2005;25(1):81\u20139.","journal-title":"Semin Neurol"},{"issue":"3","key":"1048_CR122","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/S1389-9457(02)00014-X","volume":"3","author":"G Plazzi","year":"2002","unstructured":"Plazzi G, Montagna P, Meletti S, Lugaresi E. Polysomnographic study of sleeplessness and oneiricisms in the alcohol withdrawal syndrome. Sleep Med. 2002;3(3):279\u201382.","journal-title":"Sleep Med"},{"key":"1048_CR123","doi-asserted-by":"crossref","unstructured":"Kapur VK, Auckley DH, Chowdhuri S, Kuhlmann DC, Mehra R, Ramar K, et al. Clinical practice guideline for diagnostic testing for adult obstructive sleep apnea: an American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med. 2017;13(3):479\u2013504.","DOI":"10.5664\/jcsm.6506"},{"issue":"7","key":"1048_CR124","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.5665\/sleep.5962","volume":"39","author":"L Donovan","year":"2016","unstructured":"Donovan L, Kapur V. Prevalence and characteristics of central compared to obstructive sleep apnea: analyses from the sleep heart health study cohort. Sleep. 2016;39(7):1353\u20139.","journal-title":"Sleep"},{"issue":"2","key":"1048_CR125","doi-asserted-by":"publisher","first-page":"131","DOI":"10.5664\/jcsm.27760","volume":"6","author":"KG Johnson","year":"2010","unstructured":"Johnson KG, Johnson DC. Frequency of sleep apnea in stroke and TIA patients: a meta-analysis. J Clin Sleep Med. 2010;6(2):131\u20137.","journal-title":"J Clin Sleep Med"},{"issue":"2","key":"1048_CR126","first-page":"217","volume":"134","author":"TD Bradley","year":"1986","unstructured":"Bradley TD, et al. Clinical and physiologic heterogeneity of the central sleep apnea syndrome. Am Rev Respir Dis. 1986;134(2):217\u201321.","journal-title":"Am Rev Respir Dis"},{"issue":"2","key":"1048_CR127","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1164\/ajrccm.150.2.8049835","volume":"150","author":"A Xie","year":"1994","unstructured":"Xie A, Wong B, Phillipson EA, Slutsky AS, Bradley TD. Interaction of hyperventilation and arousal in the pathogenesis of idiopathic central sleep apnea. Am J Respir Crit Care Med. 1994;150(2):489\u201395.","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"1048_CR128","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1093\/sleep\/25.6.615","volume":"25","author":"R Lydic","year":"2002","unstructured":"Lydic R, Baghdoyan HA. Ketamine and MK-801 decrease acetylcholine release in the pontine reticular formation, slow breathing, and disrupt sleep. Sleep. 2002;25(6):617\u201322.","journal-title":"Sleep"},{"key":"1048_CR129","doi-asserted-by":"crossref","unstructured":"Serrano Merino J, P\u00e9rula de Torres L\u00c1, Bardwell WA, Mu\u00f1oz G\u00f3mez R, Rold\u00e1n Villalobos A, Feu Collado N, et al. Impact of positive pressure treatment of the airway on health-related quality of life in elderly patients with obstructive sleep apnea. Biol Res Nurs. 2018;20(4):452\u201361.","DOI":"10.1177\/1099800418774633"},{"issue":"11","key":"1048_CR130","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.5664\/jcsm.6792","volume":"13","author":"H Walia","year":"2017","unstructured":"Walia H, et al. Impact of sleep-disordered breathing treatment on quality of life measures in a large clinic-based cohort. J Clin Sleep Med. 2017;13(11):1255\u201363.","journal-title":"J Clin Sleep Med"},{"issue":"1","key":"1048_CR131","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s12931-018-0761-8","volume":"19","author":"X Wang","year":"2018","unstructured":"Wang X, Zhang Y, Dong Z, Fan J, Nie S, Wei Y. Effect of continuous positive airway pressure on long-term cardiovascular outcomes in patients with coronary artery disease and obstructive sleep apnea: a systematic review and meta-analysis. Respir Res. 2018;19(1):61.","journal-title":"Respir Res"},{"key":"1048_CR132","doi-asserted-by":"crossref","unstructured":"Chen L, Kuang J, Pei JH, Chen HM, Chen Z, Li ZW, et al. Continuous positive airway pressure and diabetes risk in sleep apnea patients: a systemic review and meta-analysis. Eur J Intern Med. 2017;39:39\u201350.","DOI":"10.1016\/j.ejim.2016.11.010"},{"key":"1048_CR133","doi-asserted-by":"crossref","unstructured":"Epstein LJ, Kristo D, Strollo PJ Jr, Friedman N, Malhotra A, Patil SP, et al. Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults. J Clin Sleep Med. 2009;5(3):263\u201376.","DOI":"10.5664\/jcsm.27497"},{"issue":"1","key":"1048_CR134","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1001\/archneur.69.1.145","volume":"69","author":"FI Tezer","year":"2012","unstructured":"Tezer FI, et al. Daytime polysomnography recording in LIG1-related limbic encephalitis. Arch Neurol. 2012;69(1):145\u20136.","journal-title":"Arch Neurol"},{"issue":"4475","key":"1048_CR135","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1126\/science.7434029","volume":"210","author":"CA Czeisler","year":"1980","unstructured":"Czeisler CA, et al. Human sleep: its duration and organization depend on its circadian phase. Science. 1980;210(4475):1264\u20137.","journal-title":"Science"},{"issue":"4","key":"1048_CR136","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.psc.2015.07.012","volume":"38","author":"SM Abbott","year":"2015","unstructured":"Abbott SM, Reid KJ, Zee PC. Circadian rhythm sleep-wake disorders. Psychiatr Clin North Am. 2015;38(4):805\u201323.","journal-title":"Psychiatr Clin North Am"}],"container-title":["Current Neurology and Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-020-01048-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11910-020-01048-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-020-01048-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T07:46:16Z","timestamp":1625125576000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11910-020-01048-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,10]]},"references-count":136,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["1048"],"URL":"https:\/\/doi.org\/10.1007\/s11910-020-01048-0","relation":{},"ISSN":["1528-4042","1534-6293"],"issn-type":[{"value":"1528-4042","type":"print"},{"value":"1534-6293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,10]]},"assertion":[{"value":"10 June 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Dr. GS Day serves as a topic editor on dementia for DynaMed Plus (EBSCO Industries, Inc.), is the clinical director for the Anti-NMDA Receptor Encephalitis Foundation (uncompensated), and holds stocks (>\u2009$10,000) in ANI Pharmaceuticals (a generic pharmaceutical company). Dr. MS Blattner reports no conflicts.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"28"}}